Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

The ketogenic diet and neurodegeneration: lifeline, landmine… or something in between?

Original source

The ketogenic diet and neurodegeneration: lifeline, landmine… or something in between?You Nutrition Clinic · 19 November 2025 (opens in a new tab)

You Nutrition Clinic has a commercial interest in this subject. Compass summarises the reporting; it is not independent analysis, and it is not clinical evidence.

An expert review examines how ketogenic diets may provide an alternative fuel for brain cells in neurodegenerative diseases, including motor neurone disease (MND/ALS). It describes proposed effects on energy production and oxidative stress, based largely on biological research and laboratory or animal models.

Why this matters

The review may help explain why ketogenic approaches are being studied in MND/ALS. However, the material supplied does not show that a ketogenic diet improves symptoms, slows disease or changes treatment for people with MND/ALS.

Limitations and context

This is a sponsored expert review, not a report of a new clinical trial. The evidence described includes laboratory models and animal studies, and the supplied material does not establish a clinical benefit, an appropriate diet for people with MND/ALS or its safety for any individual. Dietary changes should not be treated as a replacement for medical care.

Summarised by Compass 27 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?